The selective Aurora B kinase inhibitor AZD1152 inhibits in vitro growth in small cell lung cancer (SCLC) cell lines

被引：0
|
作者：
Helfrich, B. [1 ]
Garcia, M. [1 ]
Haney, J. [1 ]
Bunn, P. A., Jr. [1 ]
机构：
[1] Univ Colorado, Ctr Canc, Dept Med, Aurora, CO USA
来源：
EJC SUPPLEMENTS | 2008年 / 6卷 / 12期
关键词：
D O I：
10.1016/S1359-6349(08)72222-5
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：93 / 93
页数：1
相关论文
共 50 条
  • [1] The selective aurora B kinase inhibitor AZD1152-HQPA inhibits in vitro growth of small cell lung cancer (SCLC) cell lines
    Helfrich, Barbara
    Theodoro, Mariana
    Varella-Garcia, Marilelia
    Haney, Jerry
    Bemis, Lynne
    Bunn, Paul
    CANCER RESEARCH, 2009, 69
  • [2] Barasertib (AZD1152), a Small Molecule Aurora B Inhibitor, Inhibits the Growth of SCLC Cell Lines In Vitro and In Vivo
    Helfrich, Barbara A.
    Kim, Jihye
    Gao, Dexiang
    Chan, Daniel C.
    Zhang, Zhiyong
    Tan, Aik-Choon
    Bunn, Paul A., Jr.
    MOLECULAR CANCER THERAPEUTICS, 2016, 15 (10) : 2314 - 2322
  • [3] The Aurora Kinase B Inhibitor AZD1152-HQPA Inhibitor in Small Cell Lung Cancer (SCLC)
    Helfrich, Barbara
    Kim, Jihye
    Gao, Dexiang
    Chan, Dan
    Tan, Aik-Choon
    Bunn, Paul A., Jr.
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S363 - S363
  • [4] EVALUATION OF THE SELECTIVE AURORA B KINASE INHIBITOR AZD1152 IN SCLC LINES WITH AND WITHOUT MYC FAMILY AMPLIFICATION.
    Helfrich, Barbara
    Chan, Daniel
    Zhang, Zhiyong
    Li, Xian
    Gao, Dexiang
    Bunn, Paul A.
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S775 - S775
  • [5] AZD1152, a selective inhibitor of Aurora B kinase, inhibits human tumor xenograft growth by inducing apoptosis
    Wilkinson, Robert W.
    Odedra, Rajesh
    Heaton, Simon P.
    Wedge, Stephen R.
    Keen, Nicholas J.
    Crafter, Claire
    Foster, John R.
    Brady, Madeleine C.
    Bigley, Alison
    Brown, Elaine
    Byth, Kate F.
    Barrass, Nigel C.
    Mundt, Kirsten E.
    Foote, Kevin M.
    Heron, Nicola M.
    Jung, Frederic H.
    Mortlock, Andrew A.
    Boyle, F. Thomas
    Green, Stephen
    CLINICAL CANCER RESEARCH, 2007, 13 (12) : 3682 - 3688
  • [6] High Activity of the Aurora B kinase Inhibitor AZD1152 on Melanoma Cell Lines Irrespective of BRAF Mutation
    Porcelli, L.
    Quatrale, A. E.
    Guida, G.
    Mantuano, P.
    Zanna, P.
    Strippoli, S.
    Guida, S.
    Grieco, C.
    Albano, A.
    Tommasi, S.
    Pinto, R.
    De Summa, S.
    Paradiso, A.
    Guida, M.
    Azzariti, A.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2013, 11 : 69 - 70
  • [7] The Aurora kinase inhibitor AZD1152 inhibits cell proliferation, modifies the cell cycle and enhances chemotherapeutic activity in vitro models
    Azzariti, A.
    Porcelli, L.
    Simone, G. M.
    Paradiso, A.
    EJC SUPPLEMENTS, 2007, 5 (08): : 19 - 19
  • [8] Phase I and pharmacological study of AZD1152, a selective inhibitor of aurora kinase B
    Boss, D. S.
    Witteveen, P. O.
    Mergui, M.
    van der Sar, J.
    Stockman, P. K.
    Voest, E. E.
    Beijnen, J. H.
    Schellens, J. H. M.
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2009, 68 (05) : 782 - 783
  • [9] Identification of genes that confer tumor cell resistance to the Aurora B kinase inhibitor, AZD1152
    Guo, J.
    Anderson, M. G.
    Tapang, P.
    Palma, J. P.
    Rodriguez, L. E.
    Niquette, A.
    Li, J.
    Bouska, J. J.
    Wang, G.
    Semizarov, D.
    Albert, D. H.
    Donawho, C. K.
    Glaser, K. B.
    Shah, O. J.
    PHARMACOGENOMICS JOURNAL, 2009, 9 (02): : 90 - 102
  • [10] Aurora kinase B inhibitor barasertib (AZD1152) inhibits glucose metabolism in gastric cancer cells
    He, Jian
    Qi, Zihao
    Zhang, Xiaofei
    Yang, Yufei
    Liu, Fei
    Zhao, Guangfa
    Wang, Ziliang
    ANTI-CANCER DRUGS, 2019, 30 (01) : 19 - 26
12345